Johnson & Johnson
People also watch:PGMRKKOPFEXOM
125.150.26 (0.21%)

After hours: 125.150.00 (0.00%) as of 4:59 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close124.89
Bid124.82 x 300
Ask125.25 x 100
52wk Range81.79 - 126.07
Day's Range124.75 - 125.55
Avg Vol (3m)7,062,514
As of 4:00 PM EDT. Market closed.
  • 3 Things to Watch as Celgene Corporation Reports Earnings
    Motley Fool3 hours ago

    3 Things to Watch as Celgene Corporation Reports Earnings

    Increasing Revlimid sales is key, but don't forget about Otezla.

  • Reuters4 hours ago

    FDA enhances warnings on group of strong antibiotics

    The U.S. Food and Drug Administration has enhanced warnings of side effects of a group of strong antibiotics used to treat a variety of respiratory and urinary tract infections and limited their use to patients with no alternatives. The antibiotics known as fluoroquinolones include Johnson & Johnson's Levaquin, Bayer's Cipro extended-release tablets and Merck Inc's Avelox. The FDA added a box warning to the antibiotics in July 2008 to inform users about the increased risk of tendinitis in which the tissue connecting muscle to bone becomes inflamed.